Top

Obesity Surgery

Published in:

01-11-2020 | Sleeve Gastrectomy | Letter to Editor/LED Reply

Why Choosing the Roux-en-Y Gastric Bypass in a Morbid Obese with a History of a Failed Nissen Fundoplication Is Not a Dogma

Authors: Antonio Iannelli, Sébastien Frey, Niccolo Petrucciani

Published in: Obesity Surgery | Issue 11/2020

Excerpt

Dear Editor, …

Petrucciani N, Sebastianelli L, Frey S, et al. From Nissen fundoplication to Roux-en-Y gastric bypass to treat both GERD and morbid obesity. Obes Surg. 2020;30:790–2. https://doi.org/10.1007/s11695-019-04271-y.CrossRefPubMed

Iannelli A, Amato D, Addeo P, et al. Laparoscopic conversion of vertical banded gastroplasty (Mason MacLean) into Roux-en-Y gastric bypass. Obes Surg. 2008;18:43–6. https://doi.org/10.1007/s11695-007-9255-3.CrossRefPubMed

Iannelli A, Addeo P, Dahman M, et al. Laparoscopic conversion of vertical banded gastroplasty with an antireflux wrap into Roux-en-Y gastric bypass. Obes Surg. 2007;17:901–4. https://doi.org/10.1007/s11695-007-9167-2.CrossRefPubMed

Benois M, Sebastianelli L, Morisot A, et al. Revisional but not conversional gastric bypass surgery increases the risk of leaks: review of 176 redo out of 932 consecutive cases. Obes Surg. 2018;28:2903–11. https://doi.org/10.1007/s11695-018-3311-z.CrossRefPubMed

Kauer WKH, Stein HJ. Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease. J Gastrointest Surg. 2010;14:9–16. https://doi.org/10.1007/s11605-009-1014-4.CrossRef

Kauer WKH, Stein HJ. Role of acid and bile in the genesis of Barrett’s esophagus. Chest Surg Clin N Am. 2002;12:39–45. https://doi.org/10.1016/S1052-3359(03)00064-4.CrossRefPubMed

Stenard F. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21:10348–57. https://doi.org/10.3748/wjg.v21.i36.10348.CrossRefPubMedPubMedCentral

Tack J, Pandolfino JE. Pathophysiology of gastroesophageal reflux disease. Gastroenterology. 2018;154:277–88. https://doi.org/10.1053/j.gastro.2017.09.047.CrossRefPubMed

Harrysson IJ, Cook J, Sirimanna P, et al. Systematic review of learning curves for minimally invasive abdominal surgery: a review of the methodology of data collection, depiction of outcomes, and statistical analysis. Ann Surg. 2014;260:37–45. https://doi.org/10.1097/SLA.0000000000000596.CrossRefPubMed

10.

Sharples AJ, Mahawar K. Systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2020;30:664–72. https://doi.org/10.1007/s11695-019-04235-2.CrossRefPubMed

11.

Ben Amor I, Debs T, Petrucciani N, et al. Chronic fistula post laparoscopic Nissen sleeve gastrectomy: conversion to Roux-en-Y gastric bypass. Obes Surg. 2019;29:3414–5. https://doi.org/10.1007/s11695-019-04080-3.CrossRefPubMed

12.

Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319:255–65. https://doi.org/10.1001/jama.2017.20897.CrossRefPubMedPubMedCentral

13.

DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 2014;149:328–34. https://doi.org/10.1001/jamasurg.2013.4323.CrossRefPubMed

14.

Sebastianelli L, Benois M, Vanbiervliet G, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg. 2019; https://doi.org/10.1007/s11695-019-03704-y.

15.

Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13:568–74. https://doi.org/10.1016/j.soard.2016.11.029.CrossRefPubMed

16.

Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27:3092–101. https://doi.org/10.1007/s11695-017-2748-9.CrossRefPubMed

17.

Csendes A, Burgos A, Smok G, et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10:259–64. https://doi.org/10.1016/j.gassur.2005.06.006.CrossRefPubMed

18.

Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22:764–72. https://doi.org/10.1007/s11695-011-0531-x.CrossRefPubMed

19.

Andrew B, Alley JB, Aguilar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32:930–6. https://doi.org/10.1007/s00464-017-5768-6.CrossRefPubMed

20.

Felsenreich DM, Langer FB, Bichler C, et al. Roux-en-Y gastric bypass as a treatment for Barrett’s esophagus after sleeve gastrectomy. Obes Surg. 2019; https://doi.org/10.1007/s11695-019-04292-7.

Title: Why Choosing the Roux-en-Y Gastric Bypass in a Morbid Obese with a History of a Failed Nissen Fundoplication Is Not a Dogma
Authors: Antonio Iannelli
Sébastien Frey
Niccolo Petrucciani
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Sleeve Gastrectomy
Gastric Fundoplication
Gastric Fundoplication
Barrett Esophagus
Published in: Obesity Surgery / Issue 11/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-020-04540-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Why Choosing the Roux-en-Y Gastric Bypass in a Morbid Obese with a History of a Failed Nissen Fundoplication Is Not a Dogma

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2020

Iron, Vitamin B12, Folate and Copper Deficiency After Bariatric Surgery and the Impact on Anaemia: a Systematic Review

Five-Year Outcomes of Laparoscopic Sleeve Gastrectomy in Japanese Patients with Class I Obesity

Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences

COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery

Single-Session Endoscopic Ultrasound-Directed Transgastric ERCP (“EDGE”) in a Bariatric Patient with Pancreatic Mass and Biliary Obstruction

Motivation and Weight Loss Expectations in Bariatric Surgery Candidates: Association with 1- and 2-Year Results After Bariatric Surgery